Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China 2023-08-22 17:13
Berlin Heals Holding AG welcomes Dr. Felix Baader and Roland Diggelmann as new board members Final phase of ongoing CE study started 2023-08-22 15:00
Introducing NeoMab™: GemPharmatech's Innovative Antibody Gene Humanized Mouse Model 2023-08-22 08:59
Mammotome Launches the HydroMARK™ Plus Breast Biopsy Site Marker, an Innovation for Tissue Marker Displacement 2023-08-21 22:00
Expanse Medical Welcomes Shlomi Nachman to Board of Directors 2023-08-21 21:01
Lunit Backs the Potential of Tertiary Lymphoid Structures Analysis as an Emerging Biomarker for Lung Cancer Treatment - to be presented at WCLC 2023 2023-08-21 21:00
CanariaBio Achieves Significant Milestone with FDA's Orphan Drug Designation for MAb-AR20.5 Targeting Pancreatic Cancer 2023-08-21 20:00
Zepp Health Corporation Reports Second Quarter 2023 Unaudited Financial Results 2023-08-21 18:15
Hummingbird Bioscience to Present Poster on HMBD-001 Combination Strategy for Squamous Non-Small Cell Lung Cancer at World Conference on Lung Cancer 2023 2023-08-21 17:58
So-Young Reports Unaudited Second Quarter 2023 Financial Results 2023-08-21 17:30
magAssist's NyokAssist™️ granted Designation by the FDA as a Breakthrough Device 2023-08-21 14:34
Everest Medicines Announces Partner Calliditas Therapeutics Receives FDA Priority Review for Full Approval of Nefecon® for the Treatment of IgA Nephropathy 2023-08-21 08:20
Sisram Medical to Report H1 2023 Financial Results on August 23 and Hold a Conference Call on August 24 2023-08-20 10:14
TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination 2023-08-19 04:30
3Z and biotx.ai Forge Partnership to Advance ADHD Drug Development Using AI Modelling 2023-08-18 22:45
Akeso Announced First Patient Dosed in Phase 3 Trial of Ivonescimab versus Tislelizumab for First-line Treatment of Squamous NSCLC 2023-08-18 20:00
Inmagene's anti-OX40 mAb demonstrated an extended half-life and a favorable safety profile in a Phase I study 2023-08-18 19:00
Nature-inspired pressure sensing technology aims to transform healthcare and surgical robots 2023-08-18 17:54
United Imaging Healthcare delivers its 2023 Half-Year report, with revenue growth of 26.35% in the first half of 2023 2023-08-18 17:29
JinMed (NASDAQ: ZJYL) Rings the Nasdaq Stock Market Closing Bell on August 17 2023-08-18 11:36
1 164 165 166 167 168 970